Skip to content
Clinical Trials – home

Institute Of Tropical Medicine

Research site

Belgium Nationalestraat 155, 2000 Antwerp, Belgium

  • 7 trials recruiting
  • HIV infection · Rabies · Influenza
  • Adults and children

About Specializations

Institute Of Tropical Medicine in Antwerp, Belgium specialises in clinical trials of conditions such as HIV infection, Rabies, Influenza, Influenza immunisation, and other specialisations. This site conducts important research.

Main research areas of the site

HIV and Antiretroviral Research

At the Institute Of Tropical Medicine in Antwerp, clinical research in HIV infections focuses on improving treatment options and strengthening viral control for people living with HIV. Studies in this therapeutic area are evaluating new and existing antiretroviral strategies to support better long-term care.

  • Testing simpler and more effective antiretroviral therapy approaches for adults with HIV
  • Assessing long-acting treatment options for people with an incomplete response to oral therapy
  • Evaluating new oral regimens for treatment-naïve adults living with HIV-1

This work aims to improve treatment effectiveness, support viral suppression, and expand options for different patient needs.

Bacterial Infections and Sexually Transmitted Disease Prevention

Research in bacterial infections at this site includes major efforts in sexually transmitted infections, especially among populations at higher risk. The studies are designed to reduce infection rates and better understand prevention strategies for chlamydia, gonorrhea, and syphilis.

  • Evaluating doxycycline-based prevention for bacterial STIs in people living with HIV and in those using HIV-PrEP
  • Studying whether different prevention schedules can lower infection risk more effectively
  • Exploring the impact of post-exposure prevention on antimicrobial resistance

The goal is to improve STI prevention while also monitoring how prevention approaches may affect antibiotic resistance.

Viral Vaccines and Immunology

A strong part of the clinical research portfolio at the Department of Clinical Sciences involves virus diseases and vaccine research. These studies examine immune responses, safety, and real-world protection against infections such as influenza, respiratory syncytial virus, yellow fever, rabies, herpes simplex, and mpox.

  • Testing vaccines to prevent influenza and improve protection in healthy volunteers
  • Comparing immune responses to rabies and yellow fever vaccination by route of administration
  • Assessing vaccine safety and immune response for RSV, mpox, and herpes simplex prevention

These trials aim to strengthen vaccine protection, refine vaccination strategies, and better understand immune responses across different viral infections.

Behavior, Chemsex-Related Drug Use, and Prevention Support

The site also conducts research in psychiatry and psychology, with a focus on behavior and behavior mechanisms linked to sexual health. Current studies examine craving and the use of chemsex-related drugs, looking at ways to support healthier behavior and reduce risk.

  • Evaluating whether a medication plus counselling can reduce craving for chemsex-associated drugs
  • Studying behavior-related factors that may influence prevention and treatment outcomes
  • Supporting harm-reduction approaches for people affected by substance use in sexual health settings

This research is intended to improve behavioral support, inform prevention services, and help address substance use challenges connected to sexual health.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Nationalestraat 1552000 AntwerpBelgium
Recruiting now
7 trials
Conditions studied
16

More sites in AntwerpBelgium

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

23 clinical trials

Influenza+1

Recruiting

Efficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:65+ years · Healthy volunteers
  • Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
  • Sponsor:GlaxoSmithKline Biologicals

Rabies

Recruiting

Rabies Prophylaxis in Healthy Volunteers After Rabies Virus (Inactivated) Strain Flury LEP Vaccination

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Substances:Rabies virus (inactivated) strain Flury LEP
  • Sponsor:Institute Of Tropical Medicine

A study to compare weekly or event-based use of doxycycline to prevent sexually transmitted infections in men who have sex with men and transgender women using HIV prevention medication.

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Doxycycline
  • Sponsor:Institute Of Tropical Medicine
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Institute Of Tropical Medicine

HIV infection

Recruiting

A study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Dolutegravir Sodium
  • Sponsor:Viiv Healthcare UK Limited
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Modified Vaccinia Ankara – Bavarian Nordic Live Virus
  • Sponsor:The Public Health Agency Of Sweden

Study on Doxycycline for Reducing Bacterial STIs in MSM and TGW with HIV

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Doxycycline Monohydrate
  • Sponsor:Institute Of Tropical Medicine

Immunisation+3

Not yet recruiting

SARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
  • Sponsor:Sanofi Vaccines US Inc.

Study on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
  • Sponsor:GlaxoSmithKline Biologicals

Yellow fever

Not recruiting

Study Comparing Different Injection Methods of Yellow Fever Vaccine in Adults

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Substances:Yellow fever virus strain 17D-204 (live, attenuated)
  • Sponsor:Institute Of Tropical Medicine

Escherichia infection

Not recruiting

Study on Ciprofloxacin's Effect on Antibiotic Resistance in E. coli for Healthy Individuals

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Ciprofloxacin
  • Sponsor:Institute Of Tropical Medicine

Herpes simplex

Not recruiting

Study of HSV immunotherapy (HSVTI) for healthy adults aged 18-40 and people with recurrent genital herpes aged 18-60

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Substances:GSKVX000000030810
  • Sponsor:GlaxoSmithKline Biologicals
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.